Götte M - Search Results

1

Infrared Microspectroscopy and Imaging Analysis of Inflammatory and Non-Inflammatory Breast Cancer Cells and Their GAG Secretome.

Mohamed HT, Untereiner V, Cinque G, Ibrahim SA, Götte M, Nguyen NQ, Rivet R, Sockalingum GD, Brézillon S. Mohamed HT, et al. Among authors: gotte m. Molecules. 2020 Sep 19;25(18):4300. doi: 10.3390/molecules25184300. Molecules. 2020. PMID: 32961706 Free PMC article.

2

Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.

Nikolova V, Koo CY, Ibrahim SA, Wang Z, Spillmann D, Dreier R, Kelsch R, Fischgräbe J, Smollich M, Rossi LH, Sibrowski W, Wülfing P, Kiesel L, Yip GW, Götte M. Nikolova V, et al. Among authors: gotte m. Carcinogenesis. 2009 Mar;30(3):397-407. doi: 10.1093/carcin/bgp001. Epub 2009 Jan 6. Carcinogenesis. 2009. PMID: 19126645

3

miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness.

Götte M, Mohr C, Koo CY, Stock C, Vaske AK, Viola M, Ibrahim SA, Peddibhotla S, Teng YH, Low JY, Ebnet K, Kiesel L, Yip GW. Götte M, et al. Oncogene. 2010 Dec 16;29(50):6569-80. doi: 10.1038/onc.2010.386. Epub 2010 Sep 6. Oncogene. 2010. PMID: 20818426

4

Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism.

Ibrahim SA, Yip GW, Stock C, Pan JW, Neubauer C, Poeter M, Pupjalis D, Koo CY, Kelsch R, Schüle R, Rescher U, Kiesel L, Götte M. Ibrahim SA, et al. Among authors: gotte m. Int J Cancer. 2012 Sep 15;131(6):E884-96. doi: 10.1002/ijc.27629. Epub 2012 May 30. Int J Cancer. 2012. PMID: 22573479 Free article.

5

Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation.

Hassan H, Greve B, Pavao MS, Kiesel L, Ibrahim SA, Götte M. Hassan H, et al. Among authors: gotte m. FEBS J. 2013 May;280(10):2216-27. doi: 10.1111/febs.12111. Epub 2013 Jan 31. FEBS J. 2013. PMID: 23289672 Free article.

6

Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling.

Ibrahim SA, Hassan H, Vilardo L, Kumar SK, Kumar AV, Kelsch R, Schneider C, Kiesel L, Eich HT, Zucchi I, Reinbold R, Greve B, Götte M. Ibrahim SA, et al. Among authors: gotte m. PLoS One. 2013 Dec 31;8(12):e85737. doi: 10.1371/journal.pone.0085737. eCollection 2013. PLoS One. 2013. PMID: 24392029 Free PMC article.

7

MicroRNA-dependent targeting of the extracellular matrix as a mechanism of regulating cell behavior.

Ibrahim SA, Hassan H, Götte M. Ibrahim SA, et al. Among authors: gotte m. Biochim Biophys Acta. 2014 Aug;1840(8):2609-20. doi: 10.1016/j.bbagen.2014.01.022. Epub 2014 Jan 23. Biochim Biophys Acta. 2014. PMID: 24462576 Review.

8

HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression.

Vijaya Kumar A, Salem Gassar E, Spillmann D, Stock C, Sen YP, Zhang T, Van Kuppevelt TH, Hülsewig C, Koszlowski EO, Pavao MS, Ibrahim SA, Poeter M, Rescher U, Kiesel L, Koduru S, Yip GW, Götte M. Vijaya Kumar A, et al. Among authors: gotte m. Int J Cancer. 2014 Dec 1;135(11):2579-92. doi: 10.1002/ijc.28921. Epub 2014 Apr 30. Int J Cancer. 2014. PMID: 24752740 Free article.

9

MicroRNA regulation of proteoglycan function in cancer.

Ibrahim SA, Hassan H, Götte M. Ibrahim SA, et al. Among authors: gotte m. FEBS J. 2014 Nov;281(22):5009-22. doi: 10.1111/febs.13026. Epub 2014 Nov 6. FEBS J. 2014. PMID: 25168226 Free article. Review.

10

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.

Ibrahim SA, Gadalla R, El-Ghonaimy EA, Samir O, Mohamed HT, Hassan H, Greve B, El-Shinawi M, Mohamed MM, Götte M. Ibrahim SA, et al. Among authors: gotte m. Mol Cancer. 2017 Mar 7;16(1):57. doi: 10.1186/s12943-017-0621-z. Mol Cancer. 2017. PMID: 28270211 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

519 results

Search Page